CV for Dr. Scott T. Guenthner, MD

Scott T. Guenthner M.D.
The Indiana Clinical Trials Center, PC
1100 Southfield Drive, Suite 1240
Plainfield, Indiana 46168
Phone: (317) 837-6082
Fax: (317) 837-6080



PROFESSIONAL EXPERIENCE:


03/2006 Present
President/CEO
The Indiana Clinical Trials Center, PC
Plainfield, Indiana

03/2006 Present
Primary Investigator
Dermatology
The Indiana Clinical Trials Center, PC
Plainfield, Indiana

7/2002 Present
Physician/President
Dermatologist
The Dermatology Center of Indiana, PC
Plainfield, Indiana

6/1995 8/1995
Research Assistant
College of Medicine Student Research Fellowship
University of Iowa
Iowa City, Iowa

1/1992 8/1994
Research Assistant
Complement Laboratory
University of Iowa
Iowa City, Iowa

CERTIFICATION AND LICENSURE:

7/2002
Indiana Medical License #01051021

11/2002 Present
American Board of Dermatology

02/2009- Present
Good Clinical Practice Training

HOSPITAL AFFILIATIONS:

7/2002 Present
Hendricks Regional Health
Danville, Indiana

7/2002 Present
St. Francis Hospitals and Health Services
Indianapolis, Indiana

7/2003 Present
Clarian West Medical Center
Avon, Indiana

7/2004 Present
St. Vincent Hospitals and Health Services
Indianapolis, Indiana

10/2005- Present
Community Hospitals
Indianapolis, Indiana

EDUCATION:

Graduated 5/1998
Doctor of Medicine
University of Iowa
Iowa City, Iowa

Graduated 5/1994
Bachelor of Science with Highest Distinction
Psychology
University of Iowa
Iowa City, Iowa

HONORS:

Medical:
President, Alpha Omega Alpha, Iowa Chapter, 1997
The Hancher-Finkbine Medallion, 1998

Undergraduate: Phi Beta Kappa, Junior Inductee, 1993
Cumulative GPA 4.0
University of Iowa Collegiate Scholar, 1994
Omicron Delta Kappa Province XI Leader of the Year, 1993-94

ACTIVITIES:

Medical:
President, Medical Student Ambassador Program, 1996
Medical Student Council, 1995-1998
Student Preceptor, M1 Physical Examination Skills, 1997-1998

Undergraduate: Co-President, Phi Beta Kappa
General Council, Omicron Delta Kappa
Volunteer, Johnson County Big Brothers/Big Sisters Program

POST GRADUATE TRAINING:

7/1999 6/2002
Residency
Dermatology
Indiana University
Indianapolis, Indiana

FELLOWSHIPS:

7/1998 6/1999
Transitional Internship
St. Vincent Hospital and Health Services
Indianapolis, Indiana
MEMBERSHIPS/COMMITTEES:

7/2002 Present
University of Iowa Alumni Association Board of Directors

CLINICAL TRIAL EXPERIENCE:

3/2006 08/2006
COBRA Trial, Phase IV Trial of Clobex Spray for the Treatment of Plaque Psoriasis

3/2006 Present
APPLES Trial, Phase IV Study of Protopic Ointment Safety and Outcomes in the Treatment of Atopic Dermatitis

3/2006 Present
Amgen Phase IV Five year Study of Enbrel Safety (OBSERVE)

6/2006-Present
Genentech Phase IV Study of Raptiva Safety (RESPONSE)

8/2007-3/2008
Genentech Phase III Study of Raptiva in TNF- Alpha Biologic Failures

10/2007-12/2007
Novum Phase III Study of Brand vs Generic Benzaclin Gel Efficacy and Safety

1/2008-10/2008
Novum Phase III Study of Brand vs. Generic Duac Gel Efficacy and Safety

3/2008-2/2009
Genentech Phase III Study of Raptiva Effectiveness for Scalp Psoriasis

3/2008- Present
Centocor Phase IV Study of Remicade Safety (PSOLAR)

6/2008-03/2009
Novum Phase III Study of Brand vs.Generic Aldara Cream for the Treatment of Actinic Keratosis Efficacy and Safety

1/2009- Present
Novum Phase III Study of Brand vs. Generic Aldara Cream for the Treatment of Actinic Keratosis Efficacy and Safety

10/2008-04/2009
Peplin Phase III Study of Ingenol Mebutate Gel vs Placebo for the Treatment of Actinic Keratosis Efficacy and Safety

12/2008- Present
Abbott Phase III Study of ABT-874 vs Etanercept vs Placebo for the Treatment of Moderate to Severe Plaque Psoriasis Efficacy and Safety


1/2009-Present
Covance Phase III Study of Altretinoin vs Placebo for the Treatment of Chronic Hand Eczema Efficacy and Safety

12/2008-Present
Abbott Phase IV Study of Humira Safety for the Treatment of Plaque Psoriasis (ESPRIT Registry)

12/2008-Present
Novum Phase III Study of Brand vs Generic Protopic 0.1% for the Treatment of Atopic Dermatitis

04/2009-Present
Abbott Phase III Study, Open-label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects who Completed a Preceding Psoriasis Study with ABT-874

05/2009- Present
Galderma Phase IV Study, Open-label, 12-week Trial Assessment of Effectiveness, Safety, and Subject Satisfaction with Oracea (doxycycline, USP) Capsules 40 mg (30mg immediate release and 10 mg delayed release beads) as Monotherapy or as Add-on Therapy to Existing Topical Regimens for the Treatment of Rosacea

05/2009-Present
Peplin Phase III Study for Efficacy and Safety of PEP005 (ingenol mebutate) gel, 0.015% In patients with Actinic Keratosis on the head (face or scalp).



PROJECTS:

5/1999
Indiana University Department of Dermatology
Skin Cancer Education Project
Coordinated a skin cancer education project in which faculty and residents in the Department of Dermatology educated individuals of the community about melanoma and non-melanoma skin cancers at a local minor league baseball game.



PUBLICATIONS, ABSTRACTS , AND PRESENTATIONS:

Maves, KK, Guenthner, ST, et.al.. Cloning and characterization of the cDNA
encoding guinea pig properdin: a comparison of properdin from three species.

Immunology, 86 (3), 475-79, Nov., 1995

Guenthner, ST, Hurwitz, RM, Buckel, LJ, and Gray, HR. Cutaneous Squamous
Cell Carcinomas Consistently Show Histologic Evidence of In-Situ Changes: A
Clinical-Pathological Correlation.
Journal of the American Academy of Dermatology,
41(3), 443-48, Sept., 1999.

Guenthner, ST, Hurwitz, RM, Buckel, LJ, and Gray, HR. Cutaneous Squamous
Cell Carcinomas Consistently Show Histologic Evidence of In-Situ Changes: A
Clinical-Pathological Correlation.
Abstract, Journal of Cutaneous Pathology, 26 (9),
465, Oct., 1999.

Guenthner, ST, Hurwitz, RM, Buckel, LJ, and Gray, HR. Cutaneous Squamous
Cell Carcinomas Consistently Show Histologic Evidence of In-Situ Changes: A
Clinical-Pathological Correlation.
Poster Presentation. The American Society of
Dermatopathology Annual Meeting, San Diego, CA, Nov 4-7, 1999.

Guenthner, ST, Draft, KS, and Hood, AF. Virtual Dermatology Case, Indiana
University Department of Dermatology, May, 2000.

Piliang MP. Guenthner ST. Treadwell PA. Abnormal hair growth in a child with
atopy.
Archives of Dermatology. 137(11), 1521-6, Nov, 2001.

Jungers EA, Guenthner ST, Farmer ER, Perkins SM. A skin cancer education
initiative at a professional baseball game and results of a skin cancer survey.
Int J
Dermatol. 2003 Jul; 42(7): 524-9.


Click here to read CV as PDF